Blaustein 153 (6): 2539 E-mail: blaustein@cns.umass.edu. NEWS & VIEWS Beginning with papers submitted as of July 1, 2012, the methods sections of manuscripts submitted to Endocrinology must indicate the sex of animals used, or in the case of primary cells or cultures, the sex of animal from which they were derived. Although not required, […]
Women’s Health: An Evolving Mosaic
Animals Have a Sex, So Should Titles and Methods Sections In Endocrinology
Sex and Gender Differences in Alzheimer’s Disease
IOM SEX-SPECIFIC REPORTING OF SCIENTIFIC RESEARCH
A W O R K S H O P S U M M A R Y Theresa M. Wizemann, Ph.D., Rapporteur Board on Population Health and Public Health Practice THE NATIONAL ACADEMIES PRESS • 500 Fifth Street, NW • Washington, DC 20001 NOTICE: The project that is the subject of this report was approved by […]
The Editor Perspective: Implementing Journal Editorial Policies
Journal of the National Cancer Institute: Trailblazing the Way on Sex-Specific Reporting Excerpted from the IOM Report: The JNCI instructions for authors state that “where appropriate, clinical and epidemiologic studies should be analyzed to see if there is an effect of sex or any of the major ethnic groups. If there is no effect, it […]
Prescription for Change: Teaching New Physicians that Women Are Not Men
Women’s Health Research: Progress, Pitfalls, and Promise
Calling for Sex-Specific Reporting of Trial Results
Sex, Gender, and Health Biotechnology: Points to Consider
Background Reproductive technologies have been extensively debated in the literature. As well, feminist economists, environmentalists, and agriculturalists have generated substantial debate and literature on gender. However, the implications for women of health biotechnologies have received relatively less attention. Surprisingly, while gender based frameworks have been proposed in the context of public health policy, practice, health […]
IOM Sex Specific Reporting of Scientifc Research
Workshop Summary (2012) The 2010 IOM Report — Women’s Health Research: Progress, Pitfalls, and Promise –found that because data has not being reported by sex, progress in women’s health has been hindered. The number of women participating in clinical trials has increased but remains underrepresented. Even when women are included in trials, the results are […]
Building a Healthier Nation with Effective Communication and Legislation
NIH and FDA Medical Research Policies: Targeting Gender, Promoting Justice
The National Institutes of Health (NIH) and Food and Drug Administration (FDA) have both recently revised their policies regarding the inclusion of women in clinical trials. Pressured by women’s health activists and members of Congress, the NIH has vastly improved its policies; it now requires that women and minorities be included in clinical trials and […]
Biopsychosocial Model : Principles, Practice, and Scientific Inquiry
Francesc Borrell-Carrió, MD, Anthony L. Suchman, MD, and Ronald M. Epstein, MD ANNALS OF FAMILY MEDICINE. 2004. Abstract The biopsychosocial model is both a philosophy of clinical care and a practical clinical guide. Philosophically, it is a way of understanding how suffering, disease, and illness are affected by multiple levels of organization, from the societal […]
Poverty and Gender Leads to Biases in Research
Sex Differences and Individual Differences in Science
The Importance of Women’s Health Research
Expanding the Frontiers of Women’s Health Research
Exclusion of Women From Clinical Research
Wendy A. Rogers, PhD, Angela J. Ballantyne, PhD, Australian Gender Equity in Health Research GroupSchool of Medicine, Flinders University, Adelaide, Australia Growing evidence indicates important differences between men and women in the incidence, treatment responses, and prognosis of a range of diseases, including arthritis, depression, heart disease, and tropical and infectious diseases. These differences are […]
Evaluation of Sex Differences in Medical Device Clinical Studies
Evaluation of Sex Differences in Medical Device Clinical Studies DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Document issued on: December 19, 2011 (90 day comment period ends: March 1, 2012) This document provides guidance on the study and evaluation of sex differences in medical device clinical studies. The purpose […]
Evaluation of Gender Differences in Clinical Investigations: FDA Guidance 1993
Guidance for Institutional Review Boards and Clinical Investigators FDA Guidance On July 22, 1993, the FDA published the Guideline for the Study and Evaluation of Gender Differences in the Clinical Evaluation of Drugs, in the Federal Register [58 FR 39406]. The guideline was developed amidst growing concerns that the drug development process did not provide […]
IOM Assessment of Women’s Health Research: Progress, Pitfalls, and Promise
To achieve optimal health, it is in the nation’s best interest to consider sex and gender differences in all relevant research, and to apply findings in clinical practice, according to the Institute Of Medicine (IOM) Report on Women’s Health Research: Progress, Pitfalls and Promise, published in 2010. The findings support the need to bring sex and […]
